Management of HER2-Positive Early Breast Cancer in Italy: A Maze Presenting Opportunities and Challenges

The management of human epidermal growth factor receptor 2 (HER2)-positive early-stage breast cancer (BC) has changed in recent years thanks to the introduction of anti-HER2 agents in clinical practice as standard of care in the neoadjuvant setting. In this scenario, we probed the issue of which HER...

Descripción completa

Detalles Bibliográficos
Autores principales: Stucci, Luigia Stefania, Pisino, Marco, D’Addario, Claudia, Grassi, Teresa, Toss, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160375/
https://www.ncbi.nlm.nih.gov/pubmed/35664788
http://dx.doi.org/10.3389/fonc.2022.871160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160375/
https://www.ncbi.nlm.nih.gov/pubmed/35664788
http://dx.doi.org/10.3389/fonc.2022.871160

Ejemplares similares